NTRK2 and glioma: To further characterize which signaling pathways may be active in TrkB.T1 gliomas, 3T3/tv-a cells were maintained as previously described39 and infected with RCAS-TrkB.T1 (Fig. 5b) to explore potential mechanistic links for these effects.